COVID debates are more than just science vs. misinformation
During the time before vaccines, a friend of mine told me he was traveling home for Christmas despite the pandemic but would not visit his 93-year-old grandmother. A perfectly reasonable position: She was in a high-risk group for COVID-19 based on age. No one would want to make their loved ones sick.
And yet, how many more Christmases and how many more visits can a 93-year-old grandmother be expected to enjoy? Actuarially speaking, not visiting her may mean never seeing her again. Perhaps, if she is up for the risk, you should be too? It would also still be understandable for you to not want to bear the responsibility of making her potentially fatally ill, even if she extended the invitation.
The above dilemma is a common one in the COVID era and it does not come down to science versus misinformation. People can reach different conclusions about what the correct answer is while looking at the same data. Many of the conflicts we have over the pandemic are not about having different views of what the science says, although that certainly does happen as well. The biggest debates involve trade-offs and differences in values or priorities.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Those debates can be informed by the science. But science cannot resolve them. Science can help understanding of the risk of exposing my grandmother to COVID. It can also tell me what a normal human lifespan is. But it cannot tell me what the right answer is in terms of visiting her, at least in a way that is acceptable to everyone.
Some of the differences of opinion over business restrictions during the pandemic or mask mandates or other public policies may stem from how seriously one takes the virus. But often, they come down to valuing certain cost-benefit analyses differently. The government, of course, has to try to make these decisions based on the common good. But individual policymakers will differ, sometimes based even on their own areas of expertise.
None of this is to say there isn't a great deal of misinformation circulating, especially about the vaccines. But believing in science is not the same as believing it resolves all questions in life.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
W. James Antle III is the politics editor of the Washington Examiner, the former editor of The American Conservative, and author of Devouring Freedom: Can Big Government Ever Be Stopped?.
-
Is the royal family a security risk?
A Chinese spy's access to Prince Andrew has raised questions about Chinese influence in the UK
By Sorcha Bradley, The Week UK Published
-
Assad's future life in exile
The Explainer What lies ahead for the former Syrian dictator, now he's fled to Russia?
By Elizabeth Carr-Ellis, The Week UK Published
-
The best panettones for Christmas
The Week Recommends Supermarkets are embracing novel flavour combinations as sales of the festive Italian sweet bread soar
By Irenie Forshaw, The Week UK Published
-
Jay Bhattacharya: another Covid-19 critic goes to Washington
In the Spotlight Trump picks a prominent pandemic skeptic to lead the National Institutes of Health
By David Faris Published
-
What is Mitch McConnell's legacy?
Talking Point Moving on after a record-setting run as Senate GOP leader
By Joel Mathis, The Week US Published
-
Who will win the coming US-China trade war?
Talking Points Trump's election makes a tariff battle likely
By Joel Mathis, The Week US Published
-
The political latitude of Musk's cost-cutting task force
Talking Points A $2 trillion goal. And big obstacles in the way.
By Joel Mathis, The Week US Published
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
Should Sonia Sotomayor retire from the Supreme Court?
Talking Points Democrats worry about repeating the history of Ruth Bader Ginsburg
By Joel Mathis, The Week US Published
-
US election: who the billionaires are backing
The Explainer More have endorsed Kamala Harris than Donald Trump, but among the 'ultra-rich' the split is more even
By Harriet Marsden, The Week UK Published
-
US election: where things stand with one week to go
The Explainer Harris' lead in the polls has been narrowing in Trump's favour, but her campaign remains 'cautiously optimistic'
By Harriet Marsden, The Week UK Published